Shire Plc (SHPL)

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 592.59m
  • Volume: 0

Shire Plc Overview

Drugs group Shire Pharmaceuticals is best known for the attention deficit disorder treatments Adderall and Vyvanse. Founded in 1986 and became a listed company in 1996.
Competitors: ProStrakan, GlaxoSmithKline, Asterand, AstraZeneca, Skyepharma
Brands: Adderall, Carbatrol, Fluviral,

Key Personnel

CEO: Flemming Ornskov
CFO: Thomas Dittrich
Chairman: Susan Kilsby
Senior Independent Director: Olivier Bohuon
Non-Executive Dir: Gail D. Fosler , David Ginsburg, Albert P.L. Stroucken , Ian Clark, Sara Mathew, Steven Gillis

Contact Details

Address: 22 Grenville Street, St Helier, Jersey, JE4 8PX
Phone: +44 (0) 1256 894 000
Fax: +44 (0) 1256 894 708
Website: http://www.shire.com

Listings

Overseas Listings: NASDAQ:SHPG
ISIN: JE00B2QKY057

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

Shire Plc Market Data

Currency UK Pounds
Share Price 0.000p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 592.59m

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

Shire Plc Key Personnel

Chair Susan Kilsby
CEO Flemming Ornskov
CFO Thomas Dittrich

Top of Page